SCHEMBL7700283

SCHEMBL7700283

C[CH]CCc1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP2D6 P10635 2/20 0.50
SLC18A2 Q05940 1/20 0.49
NQO2 P16083 1/20 0.49
CYP2C9 P11712 1/20 0.48
MTNR1A P48039 2/20 0.46
SIGMAR1 Q99720 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
ACHE P22303 1/20 0.44
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
ACP3 P15309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5609954 0.89 SIGMAR1 (0.50) CYP1A2CYP2C19CYP2D6SLC18A2NQO2
SCHEMBL10481909 0.85 SIGMAR1 (0.48) CYP1A2CYP2C19CYP2D6SLC18A2NQO2
SCHEMBL10639770 0.85 CYP1A2 (0.47) CYP1A2CYP2C19CYP2D6SLC18A2NQO2
SCHEMBL10639766 0.85 CYP1A2 (0.47) CYP1A2CYP2C19CYP2D6SLC18A2NQO2
SCHEMBL3047898 0.80 CYP1A2 (0.62) CYP1A2CYP2C19CYP2D6NQO2CYP2C9
SCHEMBL8375777 0.80 CYP1A2 (0.50) CYP1A2CYP2C19CYP2D6NQO2CYP2C9
SCHEMBL7948847 0.80 MTNR1A (0.49) CYP1A2CYP2C19CYP2D6NQO2CYP2C9
SCHEMBL143458 0.80 MTNR1A (0.49) CYP1A2CYP2C19CYP2D6NQO2CYP2C9
SCHEMBL5516425 0.80 CYP1A2 (0.48) CYP1A2CYP2C19CYP2D6SLC18A2NQO2
SCHEMBL29891134 0.80 CYP1A2 (0.48) CYP1A2CYP2C19CYP2D6SLC18A2NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021405-B1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HCMV INFECTIONS BOEHRINGER INGELHEIM CA LTD (CA) 2002-09-25 EP claimed
CN-116507633-A Glycosylated IL-2 proteins and uses thereof 阿森迪斯药物肿瘤股份有限公司 2023-07-28 CN disclosed
CN-116133676-A IL-2 sequences and uses thereof 阿森迪斯药物肿瘤股份有限公司 2023-05-16 CN disclosed
CN-1204262-C Method for producing optically active amines BASF AG (DE) 2005-06-01 CN disclosed
CN-1195764-C Transition metal complex, preparation method and use thereof BASF AG (DE) 2005-04-06 CN disclosed
CN-1496991-A Chirality monophosphorous compound and its transition metal compound 2004-05-19 CN disclosed
CN-1493576-A Chiral diphosphorus compound and its transition metal compounding product 2004-05-05 CN disclosed
CN-1131233-C Carbohydrate derivatives and their solid-phase synthesis BASF AG (DE) 2003-12-17 CN disclosed
CN-1399687-A Process for preparing optically active amines BASF AG (DE) 2003-02-26 CN disclosed
CN-1330074-A Transition metal complex, preparation method and use thereof BASF AG (DE) 2002-01-09 CN disclosed
CN-1072227-C Optically active diphosphine ligands BASF AG (DE) 2001-10-03 CN disclosed
CN-1219937-A Carbohydrate derivatives and their solid-phase synthesis BASF AG (DE) 1999-06-16 CN disclosed
CN-1202492-A Optically active diphosphine ligands BASF AG (DE) 1998-12-23 CN disclosed
CN-1105354-A Novel alkamine derivative and slat of same YAMANOUCHI PHARMA CO LTD (JP) 1995-07-19 CN disclosed
US-4783562-A Process for the preparation of trichloromethyl-substituted aromatic compounds, and trichloromethyl-substituted aromatic compounds obtained in this process BAYER AKTIENGESELLSCHAFT (DE) 1988-11-08 US disclosed
EP-0061029-B1 PROCESS FOR THE PREPARATION OF TRICHLOROMETHYL-SUBSTITUTED AROMATIC COMPOUNDS BAYER AG (DE) 1986-01-08 EP disclosed